Publications and communications of Pauline ERPICUM

Navez, M.* , Pinto Coelho, T., El Karouni Walid, ERPICUM, P., Vandermeulen, M., Lagny, M.-G., CHERAMY-BIEN, J.-P., Malisoux, C., GUARIN, C., Thierry, G., Delanaye, P., Cavalier, E., Gilbo, N., Jouret, F.* , & Detry, O.*. (15 March 2024). Development of a model of simultaneous normothermic perfusion of kidney grafts in the pig [Paper presentation]. Congrès Société Belge de Transplantation, Bruxelles, Belgium.
* These authors have contributed equally to this work.

Pinto Coelho, T., ERPICUM, P., Navez, M., Zhang, C., Detry, O., & Jouret, F. (December 2023). La mort cérébrale affecte différemment les greffons rénaux par rapport à l’arrêt circulatoire brutal [Paper presentation]. Congrès Annuel Société Francophone de Transplantation, Brest, France.

Pinto Coelho, T., Erpicum, P., Navez, M., Chenyu, Z., Detry, O., & Jouret, F. (25 September 2023). LA MORT ENCÉPHALIQUE AFFECTE LES GREFFONS RÉNAUX DE FAÇON DIFFÉRENTE PAR RAPPORT À L’ARRÊT CIRCULATOIRE BRUTAL. Néphrologie et Thérapeutique, 19 (5), 370 - 463. doi:10.1684/ndt.2023.43

Fank, H.* , Weekers, L.* , Lovinfosse, P.* , Pottel, H., Seidel, L., Jadoul, A., Bouquegneau, A., BONVOISIN, C., Bovy, C., GROSCH, S., Erpicum, P., Hustinx, R., & Jouret, F. (25 August 2023). The uptake of [18F]-fluorodeoxyglucose by the renal allograft correlates with the acute Banff scores of cortex inflammation but not with the 1-year graft outcomes. Frontiers in Transplantation, 2. doi:10.3389/frtra.2023.1236751
* These authors have contributed equally to this work.

Cirillo, A., Vandermeulen, M., Erpicum, P., Pinto Coelho, T., MEURISSE, N., Detry, O., Jouret, F., & De Tullio, P. (18 June 2023). Untargeted 1H NMR-based analysis of kidney allograft perfusates identifies a metabolomics signature of delayed graft function [Poster presentation]. Metabolomics Society, Niagara Falls, Canada.

Pinto Coelho, T., Erpicum, P., Navez, M., Zhang, C., POMA, L., Detry, O., & Jouret, F. (June 2023). #3687 KIDNEY TRANSCRIPTOME VARIES BETWEEN DONOR TYPES, WITH A DIFFERENTIAL REPONSE TO ISCHEMIC PRECONDITIONING. Nephrology Dialysis Transplantation, 38 (Supplement 1), 913. doi:10.1093/ndt/gfad063c_3687

Pinto Coelho, T., Erpicum, P., Navez, M., Zhang, C., POMA, L., Detry, O., & Jouret, F. (25 May 2023). The renal transcriptome differs between donors after circulatory death and donors after brain death, which may influence the efficience of ischemic preconditioning [Paper presentation]. BSN-SBN annual congress, Vilvoorde, Belgium.

Pinto Coelho, T., Erpicum, P., Navez, M., Zhang, C., POMA, L., Detry, O., & Jouret, F. (17 March 2023). The renal transcriptome differs between donors after circulatory death and donors after brain death, which may influence the efficiency of ischemic preconditioning [Paper presentation]. Belgian Transplantation Society Congress 2023, Brussels, Belgium.

Erpicum, P., Pinto Coelho, T., BONVOISIN, C., Bouquegneau, A., GROSCH, S., Navez, M., Vandermeulen, M., Beguin, Y., Detry, O., Jouret, F., & WEEKERS, L. (February 2023). Reprise retardée de fonction du greffon après transplantation rénale : un challenge clinique toujours d’actualité. Revue Médicale de Liège, 78 (2), 107 - 113.

Pinto Coelho, T., Erpicum, P., Navez, M., Zhang, C., Detry, O., & Jouret, F. (2023). KIDNEY TRANSCRIPTOME VARIES BETWEEN DONOR TYPES, WITH A DIFFERENTIAL REPONSE TO ISCHEMIC PRECONDITIONING [Paper presentation]. ESOT congress 2023, Athens, Greece.

ERPICUM, P., BONVOISIN, C., GROSCH, S., BOVY, C., Pinto Coelho, T., DETRY, O., JOURET, F., WEEKERS, L., & BOUQUEGNEAU, A. (May 2022). Diagnostic et prise en charge thérapeutique du rejet en transplantation rénale. Revue Médicale de Liège, 77 (5-6), 338-344.

GROSCH, S., ERPICUM, P., BOUQUEGNEAU, A., JOURET, F., & BOVY, C. (May 2022). Le glomérule dans tous ses états. Revue Médicale de Liège, 77 (5-6), 330-337.

GREGOIRE, C., SERVAIS, S., WILLEMS, E., BAUDOUX, E., LECHANTEUR, C., BRIQUET, A., Bettonville, V., DETRY, O., ERPICUM, P., JOURET, F., LOUIS, E., BARON, F., & BEGUIN, Y. (April 2022). Immunothérapie cellulaire au CHU de Liège : avancées, défis et perspectives. Revue Médicale de Liège, 77 (4), 206-211.

Erpicum, P., Grosch, S., Bonvoisin, C., Bouquegneau, A., Weekers, L., Radermacher, L., Jouret, F., LEJEUNE, M., Hougrand, O., & Bovy, C. (2022). The Case | An unusual cause of renal vascular thrombi after kidney transplantation. Kidney International, 101 (2), 427-428. doi:10.1016/j.kint.2021.08.008

VANDERMEULEN, M., ERPICUM, P., BLETARD, N., POMA, L., JOURET, F., & DETRY, O. (2022). Effect of the Combination of Everolimus and Mesenchymal Stromal Cells on Regulatory T Cells Levels and in a Liver Transplant Rejection Model in Rats. Frontiers in Immunology, 13, 877953. doi:10.3389/fimmu.2022.877953

VANDERMEULEN, M., Mohamed-Wais, M., ERPICUM, P., DELBOUILLE, M.-H., LECHANTEUR, C., BRIQUET, A., MAGGIPINTO, G., Jouret, F., Beguin, Y., & Detry, O. (2022). Infusion of allogeneic mesenchymal stromal cells after liver transplantation: Five-year follow-up. Liver Transplantation, 28, 636-646. doi:10.1002/lt.26323

VANDERMEULEN, M., ERPICUM, P., BLETARD, N., POMA, L., Drion, P., JOURET, F., & DETRY, O. (August 2021). Mesenchymal stromal cells combined with everolimus promote Treg expansion but do not synergize in a rat liver transplant rejection model. Transplant International, 34 (S1 OP519), 101.

Steichen, C., & Erpicum, P. (April 2021). Combining cell-based therapy and normothermic machine perfusion for kidney graft conditioning has gone one step further. American Journal of Transplantation, 21 (4), 1359 - 1360. doi:10.1111/ajt.16260

BOUQUEGNEAU, A., ERPICUM, P., GROSCH, S., HABRAN, L., HOUGRAND, O., HUART, J., KRZESINSKI, J.-M., Misset, B., Hayette, M.-P., DELVENNE, P., BOVY, C., Kylies, D., huber, T. B., Puelles, V. G., DELANAYE, P., & Jouret, F. (2021). COVID-19-associated nephropathy includes tubular necrosis and capillarycongestion, with evidence of SARS-CoV-2 in the nephron. Kidney International. doi:10.34067/KID.0006992020

HUART, J., BOUQUEGNEAU, A., Lutteri, L., ERPICUM, P., GROSCH, S., Résimont, G., WIESEN, P., BOVY, C., Krzesinski, J.-M., THYS, M., LAMBERMONT, B., Misset, B., Pottel, H., Mariat, C., CAVALIER, E., Burtey, S., Jouret, F., & DELANAYE, P. (23 January 2021). Proteinuria in COVID‑19: prevalence, characterization and prognostic role. Journal of Nephrology, 34 (3), 355-364. doi:10.1007/s40620-020-00931-w

BOUQUEGNEAU, A., HUART, J., LUTTERI, L., ERPICUM, P., GROSCH, S., Résimont, G., WIESEN, P., ROUSSEAU, A.-F., BOVY, C., KRZESINSKI, J.-M., THYS, M., LAMBERMONT, B., Misset, B., Pottel, H., DARCIS, G., CAVALIER, E., JOURET, F., & DELANAYE, P. (2021). Survivors of COVID-19 mostly recover from tubular proteinuria and acute kidney injury after hospital discharge. Journal of Nephrology, 34 (4), 967-969. doi:10.1007/s40620-021-01075-1

VANDERMEULEN, M., ERPICUM, P., WEEKERS, L., BRIQUET, A., LECHANTEUR, C., Detry, O., Beguin, Y., & Jouret, F. (May 2020). Mesenchymal Stromal Cells in Solid Organ Transplantation. Transplantation, 104 (5), 923-936. doi:10.1097/TP.0000000000003077

Vandermeulen, M., ERPICUM, P., POMA, L., Detry, O., & JOURET, F. (11 March 2020). Impact of mesenchymal stromal cells and/or everolimus on T-reg lymphocyte expansion in rats [Paper presentation]. Annual Meeting, Antwerp, Belgium.

ERPICUM, P., GROSCH, S., BOUQUEGNEAU, A., HUART, J., Résimont, G., BOVY, C., HABRAN, L., Delvenne, P., KRZESINSKI, J.-M., BURTEY, S., DELANAYE, P., & Jouret, F. (2020). Atteintes rénales de la COVID-19. Revue Médicale de Liège. Supplément, 75 (supplément 1), 109-S114.

ERPICUM, P., WEEKERS, L., DETRY, O., BONVOISIN, C., DELBOUILLE, M.-H., GREGOIRE, C., BAUDOUX, E., BRIQUET, A., LECHANTEUR, C., MAGGIPINTO, G., SOMJA, J., Pottel, H., Baron, F., Jouret, F., & BEGUIN, Y. (2019). Infusion of third-party mesenchymal stromal cells after kidney transplantation: a phase I-II, open-label, clinical study. Kidney International, 95, 693-707. doi:10.1016/j.kint.2018.08.046

ERPICUM, P. (2018). Les cellules stromales mésenchymateuses participent au conditionnement ischémique rénal : contribution translationnelle d’une étude clinique de phase I/II en transplantation rénale et d’un modèle murin d’ischémie/reperfusion rénale [Doctoral thesis, Université de Liège]. ORBi-University of Liège. https://orbi.uliege.be/handle/2268/315187

ERPICUM, P., Rowart, P., Defraigne, J.-O., Krzesinski, J.-M., & Jouret, F. (2018). What we need to know about lipid-associated injury in case of renal ischemia/reperfusion. American Journal of Physiology. Renal Physiology. doi:10.1152/ajprenal.00322.2018

ERPICUM, P., Rowart, P., POMA, L., KRZESINSKI, J.-M., DETRY, O., & JOURET, F. (September 2017). Administration of mesenchymal stromal cells before renal ischemia/reperfusion attenuates kidney injury and modulates renal lipid metabolism in rats. Transplant International, 30 (S2), 9 (OS004.

ERPICUM, P., Rowart, P., POMA, L., Krzesinski, J.-M., DETRY, O., & Jouret, F. (August 2017). Administration of mesenchymal stromal cells before renal ischemia/reperfusion attenuates kidney injury and may modulate renal lipid metabolism in rats. Scientific Reports, 7 (1), 8687. doi:10.1038/s41598-017-08726-z

Rowart, P., ERPICUM, P., KRZESINSKI, J.-M., Sebbagh, M., & JOURET, F. (2017). Mesenchymal Stromal Cells Accelerate Epithelial Tight Junction Assembly via the AMP-Activated Protein Kinase Pathway, Independently of Liver Kinase B1. Stem Cells International. doi:10.1155/2017/9717353

ERPICUM, P., Rowart, P., POMA, L., KRZESINSKI, J.-M., DETRY, O., & Jouret, F. (16 March 2017). intravenous administration of mesenchymal stream cells modulates renal lipid metabolism in rats [Paper presentation]. 24th Annual Meeting, Bruxelles, Belgium.

WEEKERS, L., ERPICUM, P., DETRY, O., BONVOISIN, C., DELBOUILLE, M.-H., LECHANTEUR, C., BRIQUET, A., BAUDOUX, E., JOURET, F., & BEGUIN, Y. (16 March 2017). Administration of Third-Party Mesenchymal Stromal Cells at the Time of Kidney Transplantation: Interim Safety Analysis at One-Year Follow-Up [Paper presentation]. 24th Annual Meeting, Bruxelles, Belgium.

Erpicum, P., HANSSEN, O., WEEKERS, L., LOVINFOSSE, P., Meunier, P., TSHIBANDA, L., Krzesinski, J.-M., Hustinx, R., & Jouret, F. (2017). Non-invasive approaches in the diagnosis of acute rejection in kidney transplant recipients, part II: omics analyses of urine and blood samples. NDT Plus, 1-10. doi:10.1093/ckj/sfw077

HANSSEN, O., Erpicum, P., LOVINFOSSE, P., Meunier, P., WEEKERS, L., TSHIBANDA, L., Krzesinski, J.-M., HUSTINX, R., & Jouret, F. (2017). Non-invasive approaches in the diagnosis of acute rejection in kidney transplant recipients. Part I. In vivo imaging methods. Clinical Kidney Journal, 10 (1), 97-105. doi:10.1093/ckj/sfw062

Rowart, P., Erpicum, P., Krzesinski, J.-M., Sebbagh, M., & JOURET, F. (18 November 2016). Mesenchymal stromal cells (MSC) accelerate epithelial tight junction assembly via the AMP-activated protein kinase (AMPK) pathway, independently of Liver kinase b1 (Lkb1) [Poster presentation]. American Society of Nephrology | Kidney Week, Chicago, United States.

Rowart, P., Erpicum, P., Krzesinski, J.-M., Sebbagh, M., & JOURET, F. (27 October 2016). Mesenchymal stromal cells (MSC) accelerate epithelial tight junction assembly via the AMP-activated protein kinase (AMPK) pathway, independently of Liver kinase b1 (Lkb1) [Poster presentation]. MiSOT 2016 - The 6th Expert Meeting on Therapeutic MSCs for Immune Modulation, Regensburg, Germany.

Erpicum, P., WEEKERS, L., DETRY, O., BONVOISIN, C., LECHANTEUR, C., BRIQUET, A., BAUDOUX, E., JOURET, F., & BEGUIN, Y. (28 April 2016). Administration of Third-Party Mesenchymal Stromal Cells at the Time of Kidney Transplantation: Interim Safety Analysis at One-Year Follow-Up [Paper presentation]. Annual Meeting of the BVN-SBN, Bruxelles, Belgium.

Rowart, P., Erpicum, P., Defraigne, J.-O., Krzesinski, J.-M., & Jouret, F. (2016). Type 4 dipetidyl-peptidase (DPP-4) expression is decreased at both MRNA and protein levels following renal ischemia/reperfusion in rat and man. Transplant International, 29 (suppl S2), 10-17.

WEEKERS, L., Erpicum, P., DETRY, O., BONVOISIN, C., BRIQUET, A., LECHANTEUR, C., BAUDOUX, E., JOURET, F., & BEGUIN, Y. (2016). administration of Third-Party Mesenchymal Stromal Cells at the Time of Kidney Transplantation: Interim Safety Analysis at One-Year Follow-Up. Transplant International, 29 (Suppl 2), 13 -p6.

ERPICUM, P., Rowart, P., POMA, L., KRZESINSKI, J.-M., DETRY, O., & JOURET, F. (November 2015). Impact of timing administration of mesenchymal stromal cells on serum creatinine following renal ischemia/ reperfusion in rats. Transplant International, 28 (S4), 11/O29.

WEEKERS, L., ERPICUM, P., DETRY, O., JOURET, F., LECHANTEUR, C., DELBOUILLE, M.-H., BRIQUET, A., BAUDOUX, E., & BEGUIN, Y. (November 2015). Third-party mesenchymal stem cell infusion in kidney transplant recipient: 6-month safety interim analysis. Transplant International, 28 (S4), 223-224/BO278.

Erpicum, P., Rowart, P., POMA, L., Krzesinski, J.-M., DETRY, O., & Jouret, F. (13 September 2015). IMPACT OF TIMING ADMINISTRATION OF MESENCHYMAL STROMAL CELLS ON SERUM CREATININE FOLLOWING RENAL [Paper presentation]. 17th Congress of the European Society for Organ Transplantation, Brussels, Belgium.

Rowart, P., ERPICUM, P., Defraigne, J.-O., Krzesinski, J.-M., & Jouret, F. (13 September 2015). RENAL ISCHEMIA/REPERFUSION DECREASES THE EXPRESSION OF TYPE 4 DIPEPTIDYL-PEPTIDASE (DPP-4) AT BOTH [Paper presentation]. 17th Congress of the European Society for Organ Transplantation, Brussels, Belgium.

Erpicum, P., Rowart, P., POMA, L., Krzesinski, J.-M., DETRY, O., & Jouret, F. (September 2015). Impact du moment d’administration des cellules stromales mésenchymateuses sur la fonction rénale lors d’une ischémie/reperfusion rénale. Néphrologie et Thérapeutique, 11 (5), 257. doi:10.1016/j.nephro.2015.07.002

WEEKERS, L., ERPICUM, P., DETRY, O., LECHANTEUR, C., BAUDOUX, E., JOURET, F., & BEGUIN, Y. (May 2015). Third-party mesenchymal stem cell infusion in kidney transplant recipient: 6-month safety interim analysis. American Journal of Transplantation, 15 (suppl 3).

Rowart, P., ERPICUM, P., Defraigne, J.-O., KRZESINSKI, J.-M., & JOURET, F. (24 April 2015). Renal ischemia/reperfusion decreases the expression of DPP-4 [Paper presentation]. BELGIAN SOCIETY OF PHYSIOLOGY AND PHARMACOLOGY, Bruxelles, Belgium.

Rowart, P., ERPICUM, P., Detry, O., WEEKERS, L., Grégoire, C., LECHANTEUR, C., BRIQUET, A., Beguin, Y., Krzesinski, J.-M., & Jouret, F. (2015). Mesenchymal Stromal Cell Therapy in Ischemia/Reperfusion Injury. Journal of Immunology Research, 602597. doi:10.1155/2015/602597

DETRY, O., JOURET, F., VANDERMEULEN, M., ERPICUM, P., Delens, L., GREGOIRE, C., BRIQUET, A., WEEKERS, L., BAUDOUX, E., LECHANTEUR, C., & BEGUIN, Y. (December 2014). Cellules stromales mésenchymateuses et transplantation d'organes. Revue Médicale de Liège, 69, 53-56.

Erpicum, P., DETRY, O., WEEKERS, L., BONVOISIN, C., LECHANTEUR, C., BRIQUET, A., Beguin, Y., Krzesinski, J.-M., & Jouret, F. (2014). Mesenchymal stromal cell therapy in conditions of renal ischaemia/reperfusion. Nephrology Dialysis Transplantation, 29, 1487-1493. doi:10.1093/ndt/gft538

ERPICUM, P., Krzesinski, J.-M., & Jouret, F. (2014). Place de l'AMP-activated protein kinase dans le preconditionnement ischemique renal. Néphrologie et Thérapeutique. doi:10.1016/j.nephro.2013.10.006

Hanssen, O., CASTERMANS, E., BOVY, C., WEEKERS, L., ERPICUM, P., DUBOIS, B., Bours, V., Krzesinski, J.-M., & Jouret, F. (2014). Two novel mutations of the CLDN16 gene cause familial hypomagnesaemia with hypercalciuria and nephrocalcinosis. NDT Plus, 7, 282-285. doi:10.1093/ckj/sfu019

VANDERWECKENE, P., ERPICUM, P., & Krzesinski, J.-M. (29 August 2012). Intérêt de la chronothérapie dans le traitement de l'hypertension artérielle. Revue Médicale Suisse, 8 (351), 1604-1610.